Geron Company Leadership

GERN Stock  USD 4.17  0.11  2.71%   
Geron's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Geron suggests that virtually all insiders are panicking. Geron employs about 141 people. The company is managed by 14 executives with a total tenure of roughly 25 years, averaging almost 1.0 years of service per executive, having 10.07 employees per reported executive.
Shannon Odam  President
Vice President - Human Resources
Melissa Behrs  President
Executive Vice President - Portfolio and Alliance Management

Geron's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-07-08Andrew J. GrethleinDisposed 674348 @ 4.56View
2024-06-10Faye FellerDisposed 287900 @ 4.63View
2024-06-04John A ScarlettDisposed 600000 @ 4View
Monitoring Geron's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Geron's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Geron's future performance. Based on our forecasts, it is anticipated that Geron will maintain a workforce of about 140 employees by December 2024.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Geron Management Team Effectiveness

The company has return on total asset (ROA) of (0.303) % which means that it has lost $0.303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6903) %, meaning that it created substantial loss on money invested by shareholders. Geron's management efficiency ratios could be used to measure how well Geron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.49. In addition to that, Return On Capital Employed is likely to drop to -0.71. At this time, Geron's Total Assets are very stable compared to the past year. As of the 28th of November 2024, Non Current Assets Total is likely to grow to about 55.4 M, while Non Currrent Assets Other are likely to drop about 4.5 M.
As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 599.2 M, though Net Loss is likely to grow to (121.3 M).

Geron Workforce Comparison

Geron is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,442. Geron holds roughly 141 in number of employees claiming about 4% of equities under Health Care industry.

Geron Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geron insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geron's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Geron insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.25
1
4
 674,348 
 2,728,919 
2024-06-01
1.8182
20
11
 5,057,579 
 2,691,466 
2024-03-01
6.0
6
1
 7,400,000 
 2,462 
2023-06-01
2.75
11
4
 833,894 
 140,000 
2023-03-01
1.2
12
10
 5,757,694 
 3,156,387 
2022-06-01
13.0
13
1
 1,302,699 
 35,000 
2022-03-01
7.0
7
1
 5,855,284 
 200,000 
2021-03-01
8.0
8
1
 2,404,549 
 155,400 
2020-03-01
9.0
9
1
 2,048,664 
 155,400 
2019-06-01
3.5
7
2
 425,097 
 200,635 
2018-09-01
1.1429
16
14
 1,557,314 
 1,599,750 
2015-06-01
3.5
7
2
 213,067 
 4,760 
2015-03-01
2.6667
8
3
 1,513,481 
 140,000 
2014-06-01
1.2
12
10
 406,272 
 70,450 
2013-09-01
0.4286
3
7
 13,993 
 500,000 
2013-06-01
3.3333
10
3
 312,242 
 493,843 
2013-03-01
9.0
9
1
 3,651,904 
 28,292 
2012-12-01
0.2
2
10
 16,623 
 207,500 
2012-09-01
1.3333
4
3
 153,706 
 600,000 
2012-06-01
4.0
16
4
 2,164,350 
 66,394 
2012-03-01
4.0
4
1
 1,075,000 
 70,000 
2011-12-01
2.0
2
1
 114,275 
 36,000 
2011-06-01
5.0588
86
17
 1,707,756 
 330,906 
2010-09-01
12.0
60
5
 2,295,000 
 80,000 
2010-06-01
2.1176
36
17
 851,066 
 225,117 
2010-03-01
2.5
5
2
 15,028 
 5,000 
2009-06-01
3.5556
64
18
 2,172,836 
 171,445 
2009-03-01
0.5217
12
23
 71,916 
 244,556 
2008-06-01
4.6667
42
9
 1,524,760 
 139,763 
2008-03-01
0.75
6
8
 18,846 
 159,849 
2007-06-01
5.2222
47
9
 1,813,370 
 91,631 
2006-12-01
1.0
1
1
 200,000 
 0.00 
2006-06-01
15.0
15
1
 794,710 
 29,411 
2006-03-01
1.4
7
5
 39,847 
 46,436 
2005-09-01
0.4286
3
7
 90,571 
 226,142 
2005-03-01
2.0
8
4
 64,486 
 47,816 
2004-06-01
3.0
9
3
 271,420 
 12,124 
2004-03-01
8.0
8
1
 14,216 
 0.00 
2003-12-01
0.6667
2
3
 20,625 
 41,250 
2003-09-01
0.5714
4
7
 38,450 
 66,275 

Geron Notable Stakeholders

A Geron stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Geron often face trade-offs trying to please all of them. Geron's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Geron's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joseph MDResearch PresidentProfile
John MDPresident BoardProfile
Shannon OdamVice President - Human ResourcesProfile
Melissa BehrsExecutive Vice President - Portfolio and Alliance ManagementProfile
Michelle RobertsonCFO, VPProfile
Olivia BloomCFO, Executive VP of Fin. and TreasurerProfile
Andrew GrethleinExecutive VP of Devel. and Technical OperationsProfile
Scott SamuelsChief VPProfile
Faye MDExecutive OfficerProfile
Stephen JDChief VPProfile
Aron FeingoldVice CommunicationsProfile
James MBAExecutive OfficerProfile
Anil KapurExecutive OfficerProfile
Edward KovalExecutive OfficerProfile

About Geron Management Performance

The success or failure of an entity such as Geron often depends on how effective the management is. Geron management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Geron management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Geron management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.47)(0.49)
Return On Capital Employed(0.68)(0.71)
Return On Assets(0.47)(0.49)
Return On Equity(0.74)(0.78)

Geron Workforce Analysis

Traditionally, organizations such as Geron use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Geron within its industry.

Geron Manpower Efficiency

Return on Geron Manpower

Revenue Per Employee1.7K
Revenue Per Executive16.9K
Net Loss Per Employee1.3M
Net Loss Per Executive13.2M
Working Capital Per Employee1.7M
Working Capital Per Executive16.7M
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.